T0	KEYPHRASE-NOTYPES 0 12	Lyme disease
T1	KEYPHRASE-NOTYPES 14 16	LD
T2	KEYPHRASE-NOTYPES 23 43	tick-borne infection
T3	KEYPHRASE-NOTYPES 58 68	spirochete
T4	KEYPHRASE-NOTYPES 91 101	Primary LD
T5	KEYPHRASE-NOTYPES 125 141	flu-like ifiness
T6	KEYPHRASE-NOTYPES 145 153	children
T7	KEYPHRASE-NOTYPES 184 199	diagnostic rash
T8	KEYPHRASE-NOTYPES 209 225	erythema migrans
T9	KEYPHRASE-NOTYPES 227 229	EM
T10	KEYPHRASE-NOTYPES 236 249	Rheumatologic
T11	KEYPHRASE-NOTYPES 280 306	cardiologic manifestations
T12	KEYPHRASE-NOTYPES 310 321	systemic LD
T13	KEYPHRASE-NOTYPES 337 354	primary infection
T14	KEYPHRASE-NOTYPES 358 363	weeks
T15	KEYPHRASE-NOTYPES 367 373	months
T16	KEYPHRASE-NOTYPES 394 414	initial presentation
T17	KEYPHRASE-NOTYPES 418 420	LD
T18	KEYPHRASE-NOTYPES 424 436	wide variety
T19	KEYPHRASE-NOTYPES 440 460	neurologic syndromes
T20	KEYPHRASE-NOTYPES 488 496	children
T21	KEYPHRASE-NOTYPES 501 507	adults
T22	KEYPHRASE-NOTYPES 513 515	LD
T23	KEYPHRASE-NOTYPES 530 544	acute myositis
T24	KEYPHRASE-NOTYPES 548 570	chronic encephalopathy
T25	KEYPHRASE-NOTYPES 581 593	facial palsy
T26	KEYPHRASE-NOTYPES 598 616	aseptic meningitis
T27	KEYPHRASE-NOTYPES 648 673	neurologic manifestations
T28	KEYPHRASE-NOTYPES 679 698	nThe nonspecificity
T29	KEYPHRASE-NOTYPES 702 724	clinical presentations
T30	KEYPHRASE-NOTYPES 729 740	limitations
T31	KEYPHRASE-NOTYPES 744 764	laboratory diagnosis
T32	KEYPHRASE-NOTYPES 780 789	diagnosis
T33	KEYPHRASE-NOTYPES 793 809	neuroborreliosis
T34	KEYPHRASE-NOTYPES 817 830	Lyme serology
T35	KEYPHRASE-NOTYPES 865 876	systemic LD
T36	KEYPHRASE-NOTYPES 878 893	false positives
T37	KEYPHRASE-NOTYPES 908 935	asymptomatic seroconversion
T38	KEYPHRASE-NOTYPES 937 947	antibodies
T39	KEYPHRASE-NOTYPES 951 967	oral spirochetes
T40	KEYPHRASE-NOTYPES 975 984	infection
T41	KEYPHRASE-NOTYPES 989 1015	immunologic cross reaction
T42	KEYPHRASE-NOTYPES 1019 1034	pathogens
T43	KEYPHRASE-NOTYPES 1036 1051	Several authors
T44	KEYPHRASE-NOTYPES 1072 1082	precedence
T45	KEYPHRASE-NOTYPES 1086 1103	clinical criteria
T46	KEYPHRASE-NOTYPES 1130 1149	treatment decisions
T47	KEYPHRASE-NOTYPES 1153 1161	patients
T48	KEYPHRASE-NOTYPES 1177 1179	LD
T49	KEYPHRASE-NOTYPES 1192 1215	new neurologic symptoms
T50	KEYPHRASE-NOTYPES 1226 1233	concert
T51	KEYPHRASE-NOTYPES 1239 1268	clinical manifestations
T52	KEYPHRASE-NOTYPES 1280 1282	LD
T53	KEYPHRASE-NOTYPES 1288 1297	diagnosis
T54	KEYPHRASE-NOTYPES 1301 1317	neuroborreliosis
T55	KEYPHRASE-NOTYPES 1337 1357	nBecause individuals
T56	KEYPHRASE-NOTYPES 1363 1377	systemic signs
T57	KEYPHRASE-NOTYPES 1381 1383	LD
T58	KEYPHRASE-NOTYPES 1422 1435	clinical data
T59	KEYPHRASE-NOTYPES 1439 1460	seropositive children
T60	KEYPHRASE-NOTYPES 1491 1518	initial clinical evaluation
T61	KEYPHRASE-NOTYPES 1531 1540	diagnosis
T62	KEYPHRASE-NOTYPES 1544 1560	neuroborreliosis
T63	KEYPHRASE-NOTYPES 1573 1578	range
T64	KEYPHRASE-NOTYPES 1582 1598	neurologic signs
T65	KEYPHRASE-NOTYPES 1602 1610	children
T66	KEYPHRASE-NOTYPES 1616 1638	positive Lyme serology
